ClinVar Miner

Submissions for variant NM_000214.3(JAG1):c.878G>A (p.Cys293Tyr)

dbSNP: rs1568798248
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV000696810 SCV000825389 pathogenic Alagille syndrome due to a JAG1 point mutation 2021-04-02 criteria provided, single submitter clinical testing This variant is not present in population databases (ExAC no frequency). This sequence change replaces cysteine with tyrosine at codon 293 of the JAG1 protein (p.Cys293Tyr). The cysteine residue is highly conserved and there is a large physicochemical difference between cysteine and tyrosine. This variant has been observed in individual(s) with Alagille syndrome (Invitae). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 574788). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt JAG1 protein function. For these reasons, this variant has been classified as Pathogenic.
Ambry Genetics RCV002369896 SCV002685148 uncertain significance Cardiovascular phenotype 2014-08-11 criteria provided, single submitter clinical testing The p.C293Y variant (also known as c.878G>A), located in coding exon 6 of the JAG1 gene, results from a G to A substitution at nucleotide position 878. The cysteine at codon 293 is replaced by tyrosine, an amino acid with highly dissimilar properties. This variant was not reported in population based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), NHLBI Exome Sequencing Project (ESP), and 1000 Genomes Project. In the ESP, this variant was not observed in 6503 samples (13006 alleles) with coverage at this position. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this variant remains unclear.
Gilbert/Spinner Lab, Children's Hospital of Philadelphia RCV005002150 SCV005627934 not provided Arteriohepatic dysplasia no assertion provided research

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.